Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

GLP-1 medications can cause skin and muscle issues, but treatments like ultrasound and PRP can help.

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.

GLP-1 and GLP-1/GIP agonists may increase the risk of hair loss.

Methylene blue, combined with ceramides, may reduce skin and hair side effects from GLP-1 therapy.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to weight loss-related nutrient deficiency.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

GLP-1 receptor agonists may help or harm hair health, needing more research.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

GLP-1 agonists may help treat certain skin conditions.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

More research is needed to understand if GLP-1 agonists affect hair health.

GLP-1RA medications may increase the risk of hair loss, especially in non-diabetic people.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.